ATE532071T1 - Verfahren zur verminderung von eiweiss in proben - Google Patents

Verfahren zur verminderung von eiweiss in proben

Info

Publication number
ATE532071T1
ATE532071T1 AT04104644T AT04104644T ATE532071T1 AT E532071 T1 ATE532071 T1 AT E532071T1 AT 04104644 T AT04104644 T AT 04104644T AT 04104644 T AT04104644 T AT 04104644T AT E532071 T1 ATE532071 T1 AT E532071T1
Authority
AT
Austria
Prior art keywords
methods
samples
ligand
albumin
reducing protein
Prior art date
Application number
AT04104644T
Other languages
English (en)
Inventor
William Galbraith
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE532071T1 publication Critical patent/ATE532071T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G01N2333/765—Serum albumin, e.g. HSA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT04104644T 2003-09-25 2004-09-24 Verfahren zur verminderung von eiweiss in proben ATE532071T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US50663403P 2003-09-25 2003-09-25
US50657903P 2003-09-26 2003-09-26
US53137703P 2003-12-19 2003-12-19
US10/804,592 US20050037331A1 (en) 2003-08-13 2004-03-19 Apparatuses and methods for reducing albumin in samples
US10/922,560 US7790475B2 (en) 2003-09-25 2004-08-19 Apparatuses and methods for reducing albumin in samples

Publications (1)

Publication Number Publication Date
ATE532071T1 true ATE532071T1 (de) 2011-11-15

Family

ID=34397187

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04104644T ATE532071T1 (de) 2003-09-25 2004-09-24 Verfahren zur verminderung von eiweiss in proben

Country Status (4)

Country Link
US (2) US20050037331A1 (de)
EP (1) EP1519195B1 (de)
JP (1) JP4803986B2 (de)
AT (1) ATE532071T1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094865A1 (en) * 2004-10-29 2006-05-04 Kapur Terri A Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions
GB0621452D0 (en) * 2006-10-27 2006-12-06 Ucl Business Plc Therapy for liver disease
MX350703B (es) 2009-05-13 2017-09-14 Sio2 Medical Products Inc Metodo de gasificacion para inspeccionar una superficie revestida.
WO2013170052A1 (en) 2012-05-09 2013-11-14 Sio2 Medical Products, Inc. Saccharide protective coating for pharmaceutical package
US9458536B2 (en) 2009-07-02 2016-10-04 Sio2 Medical Products, Inc. PECVD coating methods for capped syringes, cartridges and other articles
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
US9272095B2 (en) 2011-04-01 2016-03-01 Sio2 Medical Products, Inc. Vessels, contact surfaces, and coating and inspection apparatus and methods
EP2776603B1 (de) 2011-11-11 2019-03-06 SiO2 Medical Products, Inc. Passivierungs-, ph-schutz- oder schmierbeschichtung für arzneimittelverpackung, beschichtungsverfahren und vorrichtung
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
US20150297800A1 (en) 2012-07-03 2015-10-22 Sio2 Medical Products, Inc. SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS
CA2890066C (en) 2012-11-01 2021-11-09 Sio2 Medical Products, Inc. Coating inspection method
US9903782B2 (en) 2012-11-16 2018-02-27 Sio2 Medical Products, Inc. Method and apparatus for detecting rapid barrier coating integrity characteristics
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
JP6382830B2 (ja) 2012-11-30 2018-08-29 エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド 医療シリンジ、カートリッジ等上でのｐｅｃｖｄ堆積の均一性制御
US9662450B2 (en) 2013-03-01 2017-05-30 Sio2 Medical Products, Inc. Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
US9937099B2 (en) 2013-03-11 2018-04-10 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging with low oxygen transmission rate
EP2971228B1 (de) 2013-03-11 2023-06-21 Si02 Medical Products, Inc. Beschichtete verpackung
US20160017490A1 (en) 2013-03-15 2016-01-21 Sio2 Medical Products, Inc. Coating method
KR20150005226A (ko) * 2013-07-05 2015-01-14 한국전자통신연구원 혈액 전처리 장치 및 방법
WO2015148471A1 (en) 2014-03-28 2015-10-01 Sio2 Medical Products, Inc. Antistatic coatings for plastic vessels
EP3337915B1 (de) 2015-08-18 2021-11-03 SiO2 Medical Products, Inc. Pharmazeutische und andere verpackungen mit niedriger sauerstoffübertragungsrate
WO2024097706A1 (en) * 2022-11-02 2024-05-10 University Of Washington System for removing protein bound uremic toxins during hemodialysis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061466A (en) * 1974-10-16 1977-12-06 Ingvar Gosta Holger Sjoholm Biologically active composition and the use thereof
US4093612A (en) * 1975-08-04 1978-06-06 Research Corporation Selective removal of albumin from blood fluids and compositions therefore
JPH04504911A (ja) * 1989-11-08 1992-08-27 エフ エム シー コーポレーション 生物学的物質の分離及び採取様遠心分離管及び多孔性選択手段の組合せ
JPH0486554A (ja) 1990-07-30 1992-03-19 Tosoh Corp 糖化アルブミンの分析方法
GB9024771D0 (en) * 1990-11-14 1991-01-02 Axis Research Assay
DE4309410A1 (de) * 1993-03-19 1995-02-16 Stange Jan Material, Verfahren und Einrichtung zur selektiven Trennung frei gelöster und stoffgebundener Stoffe aus flüssigen Stoffgemischen sowie Verfahren zur Herstellung des Materials
CA2127605A1 (en) * 1993-12-23 1995-06-24 Peter J. Degen Affinity separation method
US5643721A (en) * 1994-02-09 1997-07-01 Abbott Laboratories Bioreagent immobilization medium
US5919626A (en) * 1997-06-06 1999-07-06 Orchid Bio Computer, Inc. Attachment of unmodified nucleic acids to silanized solid phase surfaces
SE9802213D0 (sv) * 1998-06-18 1998-06-18 Amersham Pharm Biotech Ab A method for the removal/purification of serum albumins and means for use in the method
US6680176B2 (en) * 1999-05-17 2004-01-20 The United States Of America, As Represented By The Department Of Health And Human Services Identification of candidate ligands which modulate antigen presenting cells
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
US7691645B2 (en) * 2001-01-09 2010-04-06 Agilent Technologies, Inc. Immunosubtraction method
US20030032000A1 (en) * 2001-08-13 2003-02-13 Signature Bioscience Inc. Method for analyzing cellular events
JP4139333B2 (ja) * 2001-11-09 2008-08-27 キネティック バイオシステムズ インコーポレイテッド クロマトグラフィー用の方法及び組成物
WO2004072647A1 (en) * 2003-02-07 2004-08-26 Beyond Genomics Removal of proteins from a sample

Also Published As

Publication number Publication date
US20050037331A1 (en) 2005-02-17
US20050074870A1 (en) 2005-04-07
EP1519195A3 (de) 2005-06-01
US7790475B2 (en) 2010-09-07
EP1519195B1 (de) 2011-11-02
JP4803986B2 (ja) 2011-10-26
JP2005114723A (ja) 2005-04-28
EP1519195A2 (de) 2005-03-30

Similar Documents

Publication Publication Date Title
ATE532071T1 (de) Verfahren zur verminderung von eiweiss in proben
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
DE60108848D1 (de) Verfahren und vorrichtung zur ortung und konzentration von polaren analyten mittels eines elektrischen wechselfeldes
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DE602004026912D1 (de) Formulierungen und verfahren zum denaturieren von proteinen
ATE418729T1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
ATE375003T1 (de) Apparat und methode zur abtrennung einer halbleiterscheibe von einem träger
DE50212673D1 (de) Verfahren zur automatischen regelung von fokus und beleuchtung, sowie zur objektivierten antastung des kantenortes in der optischen präzisionsmesstechnik
DE60104810D1 (de) Zellfreies Verfahren zur Herstellung von posttranslational veränderten Proteinen
DE602005021485D1 (de) Verfahren und zusammensetzungen mit molkeproteinisolaten
ATE348111T1 (de) Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes
ATE310718T1 (de) Verfahren zur herstellung von (meth)acrylsäureanhydrid
ATE372392T1 (de) Verfahren zur bestimmung der menge einer zielnukleinsäure in einer probe
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
DE50010710D1 (de) Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode
ATE416619T1 (de) Verfahren zur dearomatisierung von molkeprotein
ATE447180T1 (de) Verfahren zur vorbehandlung von proben sowie immuntestverfahren unter dessen verwendung
DE602004032345D1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE60226125D1 (de) Verfahren zur quantifizierung von glykiertem protein
DE60140251D1 (de) Verfahren zur analyse von komponenten biologischer proben
ATE246692T1 (de) Verfahren zur reinigung von phosphatidylserin
DE50207801D1 (de) Verfahren zum Nachweis prokaryontischer DNA
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
ATE427490T1 (de) Verfahren zur probenvorbehandlung sowie immunologisches testverfahren unter verwendung davon
NO20015570L (no) Karl Fischer reagens